Dirigo
I direct
Alzheimer’s Early Detection Act of 2026
The bill expands and speeds access to Alzheimer’s biomarker testing—especially for seniors and Medicaid enrollees—improving timely diagnosis and clinician decision-making, but it raises public and private costs, implementation burdens, and some risks of coverage gaps or unnecessary testing.
Hot Rock Act
The bill accelerates advanced geothermal deployment by clarifying eligibility, funding R&D, expanding mapping and permitting capacity, and building workforce pipelines — but it increases federal spending and raises environmental, equity, and public-participation risks if definitions, exclusions, or rushed implementation limit oversight or exclude smaller actors.
To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes.
The bill strengthens transparency and fiduciary accountability for PBMs to protect plan participants, but risks higher plan costs, greater administrative burdens, and potential short-term disruptions to drug coverage as the market adjusts.
Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]
The bill lowers point-of-sale drug costs and strengthens oversight and pharmacy reimbursements for FEHB beneficiaries, but those gains may raise overall FEHB program costs, risk narrower plan offerings or formularies, and create legal and state-level payment distortions.
Pharmacists Fight Back in Medicare and Medicaid Act
The bill increases transparency, forces rebates to lower patients' point-of-sale costs, and strengthens oversight of PBMs while protecting retail pharmacies, but it also raises compliance and reporting burdens, risks unintended price-shifting and higher premiums, and creates confidentiality and competition concerns.
Education Not Endless Scrolling Act
The bill uses a new federal digital-ad revenue stream to create dedicated, automatic Trust Funds that expand tutoring, local journalism support, and career-education funding—providing stable, targeted benefits to students, schools, and small businesses while locking revenue into earmarks that reduce fiscal flexibility, raise long-term baseline costs, and risk higher costs and administrative burdens for advertisers, states, and taxpayers.
Deepfake Liability Act
The bill substantially strengthens protections and faster takedown paths for victims of nonconsensual intimate imagery and deepfakes, but it raises trade-offs: higher compliance costs, greater privacy/logging risks, and real potential for overbroad takedowns and burdens on smaller platforms that could chill lawful speech and competition.
Parents Over Platforms Act
The bill strengthens privacy and parental controls for minors and gives businesses clearer, uniform rules and legal safe‑harbors, but does so at the cost of added compliance and revenue impacts for app ecosystems, potential privacy and misclassification risks from age‑verification systems, and reduced state flexibility to adopt stricter protections.
ACA Copay CAP Act of 2025
The bill reduces out-of-pocket prescription spending for many enrollees by capping annual drug costs starting in 2027, but it may raise premiums and prompt insurer cost-control measures that could limit access and will require clarifying implementation guidance.
Power of the Mint Act
The bill preserves Congressional control and prevents an unapproved Fed-issued digital currency—protecting citizens' control over monetary innovations—but risks constraining Fed independence, creating legal uncertainty for markets, and slowing potentially cost-saving payment innovation and rapid crisis responses.